These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 991901)

  • 1. Delayed toxicity of epipodophyllotoxin derivatives (VM 26 and VP 16-213), due to a local effect.
    Stähelin H
    Eur J Cancer (1965); 1976 Nov; 12(11):925-31. PubMed ID: 991901
    [No Abstract]   [Full Text] [Related]  

  • 2. Kinetics of cytotoxicity of VM-26 and VP-16-213 on L1210 leukemia and hematopoietic stem cells.
    Vietti TJ; Valeriote FA; Kalish R; Coulter D
    Cancer Treat Rep; 1978 Sep; 62(9):1313-20. PubMed ID: 688275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Schedule dependency of the antileukemic activity of the podophyllotoxin-derivative VP 16-213 (NSC-141540) in L1210 leukemia.
    Dombernowsky P; Nissen NI
    Acta Pathol Microbiol Scand A; 1973 Sep; 81(5):715-24. PubMed ID: 4771975
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of topoisomerase II in mediating epipodophyllotoxin-induced DNA cleavage.
    Ross W; Rowe T; Glisson B; Yalowich J; Liu L
    Cancer Res; 1984 Dec; 44(12 Pt 1):5857-60. PubMed ID: 6094001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 4'-Demethylepipodophyllotoxin-beta-D-glucoside: a new podophyllotoxin derivative with VM-26-like and VP-16-213-like activities.
    Gupta RS; Singh B
    J Natl Cancer Inst; 1984 Jul; 73(1):241-8. PubMed ID: 6588229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skin ulceration potential without therapeutic anticancer activity for epipodophyllotoxin commercial diluents.
    Dorr RT; Alberts DS
    Invest New Drugs; 1983; 1(2):151-9. PubMed ID: 6678864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein-linked DNA strand breaks produced by etoposide and teniposide in mouse L1210 and human VA-13 and HT-29 cell lines: relationship to cytotoxicity.
    Kerrigan D; Pommier Y; Kohn KW
    NCI Monogr; 1987; (4):117-21. PubMed ID: 3041238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delayed toxicity of 4'-demethylepipodophyllotoxin 9-(4,6-O-2-thenylidene-beta-D-glucopyranoside) (NSC-122819; VM-26) in mice.
    Avery TL; Roberts D; Price RA
    Cancer Chemother Rep; 1973 Apr; 57(2):165-73. PubMed ID: 4742496
    [No Abstract]   [Full Text] [Related]  

  • 9. Antitumor activity of the two epipodophyllotoxin derivatives VP-16 and VM-26 in preclinical systems: a comparison of in vitro and in vivo drug evaluation.
    Jensen PB; Roed H; Skovsgaard T; Friche E; Vindeløv L; Hansen HH; Spang-Thomsen M
    Cancer Chemother Pharmacol; 1990; 27(3):194-8. PubMed ID: 2265455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mutagenicity tests of etoposide and teniposide].
    Nakanomyo H; Hiraoka M; Shiraya M
    J Toxicol Sci; 1986 Apr; 11 Suppl 1():301-10. PubMed ID: 3761399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of the two epipodophyllotoxin derivatives etoposide (VP-16) and teniposide (VM-26) on cell lines established from patients with small cell carcinoma of the lung.
    Roed H; Vindelov LL; Christensen IJ; Spang-Thomsen M; Hansen HH
    Cancer Chemother Pharmacol; 1987; 19(1):16-20. PubMed ID: 3815721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response of L1210 to combinations of cytosine arabinoside and VM-26 or VP16-213.
    Rivera G; Avery T; Roberts DW
    Eur J Cancer (1965); 1975 Sep; 11(9):639-47. PubMed ID: 1220978
    [No Abstract]   [Full Text] [Related]  

  • 13. The epipodophyllotoxin derivatives VM-26 and VP-16-213, 1976-1979, a review.
    Nissen NI; Dombernowsky P; Hansen HH; Pedersen AG
    Recent Results Cancer Res; 1980; 74():98-106. PubMed ID: 7003663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative cytotoxic and cytokinetic effects of the epipodophyllotoxins 4'-demethylepipodophyllotoxin-9-(4,6-O-2-ethylidene-beta-D-glucopyranoside) and 4'-demethylepipodophyllotoxin-9-(4,6-O-2-thenylidene-beta-D-glucopyranoside) and their metabolites on human leukemic lymphoblasts.
    Dow LW; Sinkule JA; Look AT; Horvath A; Evans WE
    Cancer Res; 1983 Dec; 43(12 Pt 1):5699-706. PubMed ID: 6580063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of uptake and binding of two epipodophyllotoxin glucopyranosides, 4'-demethyl epipodophyllotoxin thenylidene-beta-D-glucoside and 4'-demethyl epipodophyllotoxin ethylidene-beta-D-glucoside, in the L1210 leukemia cell.
    Allen LM
    Cancer Res; 1978 Aug; 38(8):2549-54. PubMed ID: 667850
    [No Abstract]   [Full Text] [Related]  

  • 16. Topoisomerase-II-mediated lesions in nascent DNA: comparison of the effects of epipodophyllotoxin derivatives, VM-26 and VP-16, and 9-anilinoacridine derivatives, m-AMSA and o-AMSA.
    Woynarowski JM; Sigmund RD; Beerman TA
    Biochim Biophys Acta; 1988 May; 950(1):21-9. PubMed ID: 2833925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the inhibitory effects of VP-16-213 (etoposide) and podophyllotoxin on thymidine transport and metabolism in Ehrlich ascites tumor cells in vitro.
    Yalowich JC; Goldman ID
    Cancer Res; 1984 Mar; 44(3):984-9. PubMed ID: 6692420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Verapamil-induced augmentation of etoposide accumulation in L1210 cells in vitro.
    Yalowich JC; Ross WE
    Cancer Res; 1985 Apr; 45(4):1651-6. PubMed ID: 3978633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Etoposide and teniposide. Bioanalysis, metabolism and clinical pharmacokinetics.
    Holthuis JJ
    Pharm Weekbl Sci; 1988 Jun; 10(3):101-16. PubMed ID: 3047665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of teniposide (VM-26)-induced toxicity on mouse spermatogenesis by flow cytometry.
    Jyothi P; Jagetia GC; Krishnamurthy H
    Toxicology; 2001 Jun; 163(2-3):163-74. PubMed ID: 11516526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.